TheProfitWatch

APRE - Aprea Therapeutics, Inc. Common stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.51 -0.02 (-1.32%) --- --- --- 0.0 (0.0%) -0.02 (-1.32%) --- 0.0 (0.0%)

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.53
Diluted EPS:
-0.53
Basic P/E:
-2.8113
Diluted P/E:
-2.8113
RSI(14) 1m:
39.96
VWAP:
1.5
RVol:
2.4511

Events

Period Kind Movement Occurred At
Day Rvol 2 increase day rvol 2.07, 1.5 -0.01 (-0.66%) Oct 15 13:10
1m Price decrease 1m 1.51 -0.02 (-1.3%) Oct 15 12:31
1m Price decrease 1m 1.51 -0.02 (-1.5%) Oct 15 10:02
1m Price increase 1m 1.57 +0.05 (+2.95%) Oct 15 09:48
10m Price increase 10m 1.57 +0.07 (+5.02%) Oct 15 09:48

Related News